CoChat

A novel LRAT mutation affecting splicing in a family with early onset retinitis pigmentosa

Open access
Chen, Yabin, Huang, Li, Jiao, Xiaodong, Riazuddin, Sheikh, Riazuddin, S. Amer, Fielding Hetmancik, J. · 2018 · Human Genomics

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Retinitis pigmentosa is an important cause of severe visual dysfunction. This study reports a novel splicing mutation in the lecithin retinol acyltransferase ( LRAT ) gene associated with early onset retinitis pigmentosa and characterizes the effects of this mutation on mRNA splicing and structure. Genome-wide linkage analysis followed by dideoxy sequencing of the linked candidate gene LRAT was performed in a consanguineous Pakistani family with autosomal recessive retinitis pigmentosa. In silico prediction and minigene assays were used to investigate the effects of the presumptive splicing mutation. ARRP in this family was linked to chromosome 4q31.21-q32.1 with a maximum LOD score of 5.40. A novel homozygous intronic mutation (NM_004744.4: c.541-15T>G) was detected in LRAT . In silico tools predicted that the AG-creating mutation would activate an intronic cryptic acceptor site, but cloning fragments of wild-type and mutant sequences of LRAT into Exontrap Cloning Vector pET01 and Expression Cloning Vector pCMV-(DYKD 4 K)-C showed that the primary effect of the sequence change was to weaken the nearby authentic acceptor site and cause exon skipping, with only a small fraction of transcripts utilizing the acceptor site producing the reference transcript. The c.541-15T>G mutation in LRAT results in aberrant splicing and is therefore predicted to be causal for the early onset retinitis pigmentosa in this family. In addition, this work suggests that minigenes adapted to the specific gene and exon may need to be designed for variants in the first and last exon and intron to mimic the authentic splicing mechanism in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40246-018-0165-3

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Pedigree, LRAT Region, and sequence. a Haplotypes of the LRAT region of family 61254 showing the LRAT c.541-15T>G mutation and surrounding microsatellite markers included in Table 1. The risk haplotype is marked in black. b Electropherograms of the LRAT homozygous mutation c.541-15T>G (up, individual 7), carrier sequence (middle, individual 22), and wildtype alleles (down, individual 41)
Fig. 1 Pedigree, LRAT Region, and sequence. a Haplotypes of the LRAT region of family 61254 showing the LRAT c.541-15T>G mutation and surrounding microsatellite markers included in Table 1. The risk haplotype is marked in black. b Electropherograms of the LRAT homozygous mutation c.541-15T>G (up, individual 7), carrier sequence (middle, individual 22), and wildtype alleles (down, individual 41)CC BY · PubMed Central
Fig. 2 Fundus photographs of family 61254. a, b Oculus dexter (OD) and oculus sinister (OS) of an affected 35-year-old individual (08), which show waxy pale optic discs, attenuation of retinal arteries, bone spicule-like pigment deposits in the midperiphery of the retina, and macular changes. c, d OD and OS of an affected 10-year-old individual (32), which show attenuation of retinal arteries. e, f OD and OS of an unaffected 60-year-old individual (05), which show no signs of retinal dystrophy but does show haziness secondary to age-related cataracts
Fig. 2 Fundus photographs of family 61254. a, b Oculus dexter (OD) and oculus sinister (OS) of an affected 35-year-old individual (08), which show waxy pale optic discs, attenuation of retinal arteries, bone spicule-like pigment deposits in the midperiphery of the retina, and macular changes. c, d OD and OS of an affected 10-year-old individual (32), which show attenuation of retinal arteries. e, f OD and OS of an unaffected 60-year-old individual (05), which show no signs of retinal dystrophy but does show haziness secondary to age-related cataractsCC BY · PubMed Central
Fig. 3 Electroretinography recordings of family members of 61254. a–d ERG responses of individual 8 (affected, 35-year-old). e–h ERG responses of individual 32 (affected, 10-year-old). i–l ERG response of individual 5 (unaffected, 60-year-old). a, e, and i OD combined rod and cone response; b, f, and j OD cone response; c, g, and k OS combined rod and cone response; d, h, and l OS cone response
Fig. 3 Electroretinography recordings of family members of 61254. a–d ERG responses of individual 8 (affected, 35-year-old). e–h ERG responses of individual 32 (affected, 10-year-old). i–l ERG response of individual 5 (unaffected, 60-year-old). a, e, and i OD combined rod and cone response; b, f, and j OD cone response; c, g, and k OS combined rod and cone response; d, h, and l OS cone responseCC BY · PubMed Central
Fig. 4 Results of in silico splice prediction tools. Lowercase nucleotides indicate intron 2 sequences, upper case nucleotides indicate exon 3 sequences, and the fragment highlighted in blue is the coding region. Nucleotides marked in red indicate potential splice donor or acceptor sites. The YAG sequence is shown in yellow, the polypyrimidine tract (PPT) is shown in green, and the branch point sequence (BPS) is shown in purple. The scores calculated for wildtype sequence (WT) and mutated sequence (Mut) using Human Splice Finder, SpliceView, BDGP, and NetGene2 are displayed below each splice site. A higher score implies greater potential for a splice site. NA means no splice site predictions above threshold of the in silico tool
Fig. 4 Results of in silico splice prediction tools. Lowercase nucleotides indicate intron 2 sequences, upper case nucleotides indicate exon 3 sequences, and the fragment highlighted in blue is the coding region. Nucleotides marked in red indicate potential splice donor or acceptor sites. The YAG sequence is shown in yellow, the polypyrimidine tract (PPT) is shown in green, and the branch point sequence (BPS) is shown in purple. The scores calculated for wildtype sequence (WT) and mutated sequence (Mut) using Human Splice Finder, SpliceView, BDGP, and NetGene2 are displayed below each splice site. A higher score implies greater potential for a splice site. NA means no splice site predictions above threshold of the in silico toolCC BY · PubMed Central
Fig. 5 Splicing analysis using Exontrap pET01. a Diagram of LRAT genomic DNA, the location of the c.541-15T>G mutation and the fragment inserted into pET01 construct. In the pET01 construct, the multiple cloning site (MCS) is in an intron flanked by pre-proinsulin 5′ and 3′ exons. The primers used for cDNA amplification are within the pre-proinsulin 5′ and 3′ exons and indicated by black arrows. b Diagrams of transcript splicing of WT- and Mut- LRAT-pET01. Splicing events in the WT construct are shown by a blue line, and transcript splicing of c.541-15T>G Mut-LRAT-pET01 construct are shown by a red line. Results derived from in silico prediction (top), results obtained from minigene assay using pET01 vector (middle), and results obtained from minigene assay using pET01 vector with the splice acceptor site of 3′ exon abolished (bottom). c Electrophoresis results of cDNA amplification obtained from 293T cells transfected with empty construct pET01, wildtype construct (WT), c.541-15T>G mutant construct (Mut), modified empty construct (pET01-2), modified wildtype construct (WT-2), and modified c.541-15T>G mutant construct (Mut-2). The major PCR products of cDNA amplification from each construct as verified by sequencing are indicated in d
Fig. 5 Splicing analysis using Exontrap pET01. a Diagram of LRAT genomic DNA, the location of the c.541-15T>G mutation and the fragment inserted into pET01 construct. In the pET01 construct, the multiple cloning site (MCS) is in an intron flanked by pre-proinsulin 5′ and 3′ exons. The primers used for cDNA amplification are within the pre-proinsulin 5′ and 3′ exons and indicated by black arrows. b Diagrams of transcript splicing of WT- and Mut- LRAT-pET01. Splicing events in the WT construct are shown by a blue line, and transcript splicing of c.541-15T>G Mut-LRAT-pET01 construct are shown by a red line. Results derived from in silico prediction (top), results obtained from minigene assay using pET01 vector (middle), and results obtained from minigene assay using pET01 vector with the splice acceptor site of 3′ exon abolished (bottom). c Electrophoresis results of cDNA amplification obtained from 293T cells transfected with empty construct pET01, wildtype construct (WT), c.541-15T>G mutant construct (Mut), modified empty construct (pET01-2), modified wildtype construct (WT-2), and modified c.541-15T>G mutant construct (Mut-2). The major PCR products of cDNA amplification from each construct as verified by sequencing are indicated in dCC BY · PubMed Central
Fig. 6 a Diagram of the LRAT gene showing the location of the c.541T>G variation and the fragment inserted into the pCMV-(DYKD4K)-C construct. b Electrophoresis results of cDNA amplification obtained from 293T cells and ARPE-19 cells transfected with the wildtype construct WT, mutated construct Mut, and empty construct pCMV. c Non-transfected and transfected ARPE19 cells were treated with 0, 5 μM, and 10 μM PTC124 separately for 24 h. There were no extra transcripts under PTC124 treatment. d Diagram of transcript in which splicing of WT-LRAT-pCMV is shown by a blue line; transcript splicing of Mut-LRAT-pCMV is shown by a red line. The forward primer used in cDNA amplification is within the exon 2 of LRAT and the reverse primer binds to the construct sequence of DYKD4K epitope, which are indicated by arrows (the AG shown in the 3′ UTR of LRAT refers to the last two AG in Fig. 4). A diagram of the PCR product of cDNA amplification from each construct is also shown in d
Fig. 6 a Diagram of the LRAT gene showing the location of the c.541T>G variation and the fragment inserted into the pCMV-(DYKD4K)-C construct. b Electrophoresis results of cDNA amplification obtained from 293T cells and ARPE-19 cells transfected with the wildtype construct WT, mutated construct Mut, and empty construct pCMV. c Non-transfected and transfected ARPE19 cells were treated with 0, 5 μM, and 10 μM PTC124 separately for 24 h. There were no extra transcripts under PTC124 treatment. d Diagram of transcript in which splicing of WT-LRAT-pCMV is shown by a blue line; transcript splicing of Mut-LRAT-pCMV is shown by a red line. The forward primer used in cDNA amplification is within the exon 2 of LRAT and the reverse primer binds to the construct sequence of DYKD4K epitope, which are indicated by arrows (the AG shown in the 3′ UTR of LRAT refers to the last two AG in Fig. 4). A diagram of the PCR product of cDNA amplification from each construct is also shown in dCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 21

Metadata

Authors
Chen, Y., Huang, L., Jiao, X., Riazuddin, S., Riazuddin, S. A., & Fielding Hetmancik, J.
Affiliations
  • National Institutes of Health (US)
  • Sun Yat-sen University (CN)
  • Johns Hopkins University (US)
  • University of the Punjab (PK)
Venue
Human Genomics
Published
2018-07-04
Volume
12
Issue
1
Pages
35-35
ISSN
  • 1473-9542 (ISSN-L)
  • 1479-7364
OpenAlex
W2810078361
Cited by
18
References
19
Citations by year
2026: 3 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 1
FWCI
0.36
Type
journal article
Language
en
Open access
Licence
Locations
  • Human Genomics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Eye Institute (EYE000272)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
retinitis pigmentosa, LRAT, splicing mutation, exon skipping, intronic variants, autosomal recessive retinitis pigmentosa, consanguineous family
MeSH terms
Acyltransferases, Adult, Exons, Female, Homozygote, Humans, Introns, Genetic Linkage, Male, Middle Aged, Mutation, Pedigree, Retinitis Pigmentosa, RNA Splicing, Genome, Human, Age of Onset, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel LRAT mutation affecting splicing in a family with early onset retinitis pigmentosa. https://app.cochat.ai/papers/10.1186/s40246-018-0165-3
The paper
Chen, Y., Huang, L., Jiao, X., Riazuddin, S., Riazuddin, S. A., & Fielding Hetmancik, J. (2018). A novel LRAT mutation affecting splicing in a family with early onset retinitis pigmentosa. Human Genomics. https://doi.org/10.1186/s40246-018-0165-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.